Detailed information for compound 74502

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 277.273 | Formula: C14H15NO5
  • H donors: 1 H acceptors: 4 LogP: 1.09 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCN1C(=O)c2c(C1=O)cc(cc2)OCCCC(=O)O
  • InChi: 1S/C14H15NO5/c1-2-15-13(18)10-6-5-9(8-11(10)14(15)19)20-7-3-4-12(16)17/h5-6,8H,2-4,7H2,1H3,(H,16,17)
  • InChiKey: XWUZPZQXPHVHIP-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0059 0.0719 0.1093
Schistosoma mansoni hypothetical protein 0.0081 0.2147 0.2147
Brugia malayi Carboxylesterase family protein 0.0149 0.6579 1
Trichomonas vaginalis Clan AA, family A1, cathepsin D-like aspartic peptidase 0.0048 0 0.5
Plasmodium falciparum plasmepsin II 0.0048 0 0.5
Loa Loa (eye worm) carboxylesterase 0.0149 0.6579 1
Loa Loa (eye worm) hypothetical protein 0.0149 0.6579 1
Onchocerca volvulus 0.0079 0.1968 0.5
Toxoplasma gondii aspartyl protease ASP1 0.0048 0 0.5
Toxoplasma gondii aspartyl proteinase (eimepsin), putative 0.0048 0 0.5
Echinococcus granulosus carboxylesterase 5A 0.0149 0.6579 0.6579
Plasmodium falciparum plasmepsin I 0.0048 0 0.5
Plasmodium vivax aspartyl proteinase, putative 0.0048 0 0.5
Brugia malayi hypothetical protein 0.0079 0.1968 0.2131
Echinococcus multilocularis acetylcholinesterase 0.0149 0.6579 0.6579
Loa Loa (eye worm) acetylcholinesterase 1 0.0149 0.6579 1
Echinococcus multilocularis carboxylesterase 5A 0.0149 0.6579 0.6579
Brugia malayi Carboxylesterase family protein 0.0149 0.6579 1
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0149 0.6579 0.6579
Schistosoma mansoni hypothetical protein 0.0202 1 1
Echinococcus multilocularis acetylcholinesterase 0.0149 0.6579 0.6579
Loa Loa (eye worm) hypothetical protein 0.0097 0.3189 0.4847
Loa Loa (eye worm) hypothetical protein 0.0149 0.6579 1
Loa Loa (eye worm) hypothetical protein 0.0059 0.0719 0.1093
Brugia malayi bZIP transcription factor family protein 0.01 0.3367 0.4519
Plasmodium vivax plasmepsin IV, putative 0.0048 0 0.5
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription factor 0.01 0.3367 0.3367
Schistosoma mansoni jun-related protein 0.0081 0.2147 0.2147
Schistosoma mansoni cathepsin D (A01 family) 0.0143 0.6136 0.6136
Echinococcus granulosus acetylcholinesterase 0.0149 0.6579 0.6579
Echinococcus granulosus jun protein 0.01 0.3367 0.3367
Schistosoma mansoni hypothetical protein 0.0202 1 1
Schistosoma mansoni cathepsin D (A01 family) 0.0143 0.6136 0.6136
Plasmodium falciparum plasmepsin IV 0.0048 0 0.5
Echinococcus granulosus Basic leucine zipper bZIP transcription factor 0.01 0.3367 0.3367
Echinococcus granulosus acetylcholinesterase 0.0149 0.6579 0.6579
Plasmodium falciparum plasmepsin VI 0.0048 0 0.5
Echinococcus multilocularis jun protein 0.01 0.3367 0.3367
Echinococcus multilocularis geminin 0.0202 1 1

Activities

Activity type Activity value Assay description Source Reference
Concentration (functional) ND 0 % Reduction of Astrocyte intracellular chloride concentration at 1 mM; No data. ChEMBL. 3656355
Concentration (functional) = 76 % Reduction of Astrocyte intracellular chloride concentration at 0.05 mM. ChEMBL. 3656355
Concentration (functional) = 104 % Reduction of Astrocyte intracellular chloride concentration at 0.1 mM. ChEMBL. 3656355

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.